Whitepapers/App Notes/Posters

Case study: Challenges in manufacturing high value lyophilised oncology drugs

2
SHARES

Posted: 6 January 2021 | | No comments yet

Key features of a custom-made freeze-drying integrated solution.

A B S T R A C T

A complete integrated freeze-drying system designed for high value anticancer products consisting of a reduced foot-print freeze dryer with an innovative loading/unloading system, integrating a steam-sterilizable slider with no concealed parts which is moved by a contact-free magnetic drive mechanism. This innovative system enables the transfer device, or ‘slider’, to remain inside the chamber to undergo cleaning and sterilization in place along with the internals of the freeze dryer.

Integrated with process analytical technologies for pharmaceutical freeze-drying processes, including vacuum induced nucleation control that reduces the duration of the primary drying cycle and ensures the uniformity and homogenization of the vials in all the batches, respecting the product morphology and physiochemical properties. The system is completed with an automated inline vial management device able to reject, reintroduce and retrieve vials during loading / unloading process designed for automatic detection and treatment of vials in an automatic line.

 

ACCESS your FREE COPY

 


This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

What you’ll discover:

  • Key trends shaping the pharmaceutical formulation sector
  • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
  • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
  • And more!

Don’t miss your chance to access this exclusive report ! Access now – it’s free

The nature of the business and the products the pharmaceutical company manufacture require a high degree of flexibility and specialization. This article provides key information of the integrated solution designed in accordance with strict requirements of quality to remove risks in oncology manufacturing processes.

    To read this case study in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of Telstar

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    Share via
    Share via